NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
05/12/2021
Back to search
Official data from USPTO
VANDA PHARMACEUTICALS INC.
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
59
Latest update
05/12/2021
Trademark type
Combined
Nice classes
5
Filing date
10/30/2007
Registration date
01/31/2012
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/12/2021
Last transaction
05/12/2021
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
01/11/2010
First use in commerce
01/11/2010
Drawing code
3
Owner type
03
Owner location
Washington, DC, US
Examiner
JOINER, KATINA JACKSON
Law office
L40
Current location
GENERIC WEB UPDATE
Mark description
The mark consists of stylized text "VANDA" above stylized text "PHARMACEUTICALS INC.", each to the right of an irregular shape.
Holders and representatives
Holders
Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc.
Representatives
Jayme M. Torelli Hoffman Warnick LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations acting on the central nervous system
Publications
History of USPTO decisions and trademark events.
59 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
05/12/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
05/12/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/12/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
02/02/2021
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/31/2021
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
03/31/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03/31/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/31/2017
E815
TEAS SECTION 8 & 15 RECEIVED
02/02/2017
A7OK
AMENDMENT UNDER SECTION 7 - PROCESSED
06/15/2012
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/31/2012
ES7R
TEAS SECTION 7 REQUEST RECEIVED
05/15/2012
R.PR
REGISTERED-PRINCIPAL REGISTER
01/31/2012
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE MAILED
12/30/2011
REGV
LAW OFFICE REGISTRATION REVIEW COMPLETED
12/29/2011
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
12/29/2011
SUPC
STATEMENT OF USE PROCESSING COMPLETE
12/19/2011
IUAF
USE AMENDMENT FILED
12/16/2011
EISU
TEAS STATEMENT OF USE RECEIVED
12/16/2011
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
05/24/2011
EX5G
SOU EXTENSION 5 GRANTED
05/23/2011
EXT5
SOU EXTENSION 5 FILED
05/20/2011
EEXT
SOU TEAS EXTENSION RECEIVED
05/20/2011
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
12/04/2010
EX4G
SOU EXTENSION 4 GRANTED
12/03/2010
EXT4
SOU EXTENSION 4 FILED
11/30/2010
EEXT
SOU TEAS EXTENSION RECEIVED
11/30/2010
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST MAILED
06/22/2010
EX3G
SOU EXTENSION 3 GRANTED
06/21/2010
EXT3
SOU EXTENSION 3 FILED
06/15/2010
EEXT
SOU TEAS EXTENSION RECEIVED
06/15/2010
EX2G
SOU EXTENSION 2 GRANTED
12/07/2009
EXT2
SOU EXTENSION 2 FILED
12/01/2009
EEXT
SOU TEAS EXTENSION RECEIVED
12/01/2009
EX1G
SOU EXTENSION 1 GRANTED
07/17/2009
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/15/2009
EXT1
SOU EXTENSION 1 FILED
06/22/2009
EEXT
SOU TEAS EXTENSION RECEIVED
06/22/2009
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
12/30/2008
PUBO
PUBLISHED FOR OPPOSITION
10/07/2008
NPUB
NOTICE OF PUBLICATION
09/17/2008
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/02/2008
CNEA
EXAMINERS AMENDMENT MAILED
08/27/2008
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/26/2008
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/26/2008
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/26/2008
XAEC
EXAMINER'S AMENDMENT ENTERED
08/26/2008
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/26/2008
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/13/2008
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/12/2008
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/12/2008
DMCC
DATA MODIFICATION COMPLETED
02/13/2008
ALIE
ASSIGNED TO LIE
02/12/2008
CEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION MAILED
02/12/2008
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
02/12/2008
DOCK
ASSIGNED TO EXAMINER
02/11/2008
MDSC
NOTICE OF DESIGN SEARCH CODE MAILED
11/03/2007
NWAP
NEW APPLICATION ENTERED
11/02/2007
Continuous trademark protection
Get notified about every new filing that threatens VANDA PHARMACEUTICALS INC. or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.